Aspen Aerogels, Inc. (NYSE:ASPN – Get Free Report) CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the sale, the chief financial officer now directly owns 20,790 shares in the company, valued at $626,610.60. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Aspen Aerogels Stock Performance
ASPN opened at $28.75 on Friday. Aspen Aerogels, Inc. has a 1-year low of $5.94 and a 1-year high of $33.15. The company has a market cap of $2.19 billion, a price-to-earnings ratio of -65.34 and a beta of 2.15. The company’s fifty day moving average price is $24.57 and its two-hundred day moving average price is $22.22. The company has a current ratio of 4.01, a quick ratio of 3.29 and a debt-to-equity ratio of 0.24.
Aspen Aerogels (NYSE:ASPN – Get Free Report) last posted its earnings results on Wednesday, August 7th. The construction company reported $0.21 earnings per share for the quarter, topping analysts’ consensus estimates of $0.05 by $0.16. Aspen Aerogels had a negative net margin of 10.73% and a negative return on equity of 6.35%. The company had revenue of $117.80 million for the quarter, compared to analyst estimates of $101.99 million. During the same quarter in the prior year, the business posted ($0.22) EPS. The firm’s revenue was up 144.4% compared to the same quarter last year. On average, analysts expect that Aspen Aerogels, Inc. will post 0.12 EPS for the current fiscal year.
Institutional Inflows and Outflows
Analyst Ratings Changes
ASPN has been the topic of several recent analyst reports. Canaccord Genuity Group upped their price target on shares of Aspen Aerogels from $18.00 to $28.00 and gave the company a “buy” rating in a research report on Friday, May 3rd. Piper Sandler raised their target price on Aspen Aerogels from $30.00 to $36.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 29th. HC Wainwright boosted their price target on Aspen Aerogels from $25.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, August 9th. Benchmark reaffirmed a “buy” rating and set a $14.00 price objective on shares of Aspen Aerogels in a research report on Thursday, August 8th. Finally, Barclays started coverage on shares of Aspen Aerogels in a research report on Tuesday, August 6th. They set an “overweight” rating and a $27.00 target price on the stock. One investment analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Aspen Aerogels currently has a consensus rating of “Moderate Buy” and a consensus target price of $29.70.
Get Our Latest Stock Report on Aspen Aerogels
Aspen Aerogels Company Profile
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Featured Stories
- Five stocks we like better than Aspen Aerogels
- The Basics of Support and Resistance
- Does A&F’s Q2 Earnings Win Point to a Strong Holiday Season?
- Learn Technical Analysis Skills to Master the Stock Market
- Best Buy Stock Flashes Bullish Signal, Challenges Remain
- Why is the Ex-Dividend Date Significant to Investors?
- Affirm Shows Buy-Now-Pay-Later Is Here to Stay in Latest Results
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.